[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334982-105":59,"doc-detail-334982-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","melanoma-progression-and-prognostic-models-drawn-from-single-cell-spatial-maps-of-benign-and-malignant-tumors-genetics","Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors - Genetics","","Melanoma clinical outcomes arise from genetic programs operating within tumor cells and their microenvironment, including spatially organized molecular states that remain incompletely characterized. Using single-cell RNA-based spatial molecular imaging (RNA-SMI) on archival patient tumors, the study maps gene expression across 203,472 cells in benign nevi and primary and metastatic melanomas. Spatial clustering and comparative analyses reveal gene signatures linked to proliferation, metabolism, and malignancy, validated by protein expression. Metastatic niches show up-regulation of CDK2 and FABP5, which independently predict poor outcome in 473 patients.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/melanoma-progression-and-prognostic-models-drawn-from-single-cell-spatial-maps-of-benign-and-malignant-tumors-genetics/334982/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/melanoma-progression-and-prognostic-models-drawn-from-single-cell-spatial-maps-of-benign-and-malignant-tumors-genetics/334982.png","ImageObject",300,407,{"name":92,"@type":93},"Maeve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What approach is used to study spatial gene expression in melanoma?","Question",{"text":112,"@type":113},"The study uses single-cell RNA-based spatial molecular imaging (RNA-SMI) to visualize in situ gene expression from patient-derived FFPE tumor specimens.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many cells and what tumor types are analyzed?",{"text":117,"@type":113},"Spatial gene expression is examined across 203,472 cells in benign and malignant melanocytic neoplasms, including melanocytic nevi, primary invasive melanomas, and metastatic melanomas.",{"name":119,"@type":110,"acceptedAnswer":120},"Which gene markers from metastatic niches relate to prognosis?",{"text":121,"@type":113},"Metastatic niches show up-regulation of CDK2 and FABP5, and both independently predict poor clinical outcome in melanoma patients based on Cox regression analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334982,1791045012,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":4},5909877438554,"https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272","GENETICS  \nMelanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors  \nNick R. Love1, Claire Williams2, Emily E. Killingbeck2, Alexander Merleev1, Mohammad Saffari Doost1, Lan Yu1, John D. McPherson3, Hidetoshi Mori4, Alexander D. Borowsky4, Emanual Maverakis1, Maija Kiuru1,4*  \nMelanoma clinical outcomes emerge from incompletely understood genetic mechanisms operating within the tumor and its microenvironment. Here, we used single-cell RNA-based spatial molecular imaging (RNA-SMI) inpatient-derived archival tumorsto reveal clinically relevant markers of malignancy progression and prognosis. We examined spatial gene expression of 203,472 cells inside benign and malignant melanocytic neoplasms, including melanocytic nevi and primary invasive and metastatic melanomas. Algorithmic cell clustering paired with intratumoral comparative two-dimensional analyses visualized synergistic, spatial gene signatures linking cellular proliferation, metabolism, and malignancy, validated by protein expression. Metastatic niches included up-regulation of CDK2 and FABP5, which independently predicted poor clinical outcome in 473 patients with melanoma via Cox regression analysis. More generally, our work demonstrates a framework for applying single-cell RNA-SMI technology toward identifying gene regulatory landscapes pertinent to cancer progression and patient survival.  \ncopyright © 2024 the Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. no claim to original U.S.  \nGovernment Works. distributed under a creative commons Attribution noncommercial License 4.0 (cc BY-nc) .  \nINTRODUCTION  \nMelanocytic tumors—both benign and malignant—exhibit a great variety of morphologies and clinical outcomes (1, 2) . For example, the melanocytes of nevi (benign melanocytic neoplasms colloquially known as “moles”) initially replicate, quiesce, and remain confined within their tissue microenvironment. The melanocytes of melanoma, in contrast, have the capacity to aggressively proliferate, invade nearby tissues, and metastasize. Although both nevi and melanoma can have similar driver mutations, most commonly in BRAF and NRAS, melanomas are known to harbor a multitude of oncogenic mutations that are not fully understood but differ from the mutations identified innevi (2). In addition to individual DNA mutations, the clinical fates of patients with melanocytic neoplasms emerge from a combination of incompletely understood molecular, genetic, and cellular mechanisms interacting within the tumor microenvironment.  \nUnregulated melanocyte cell proliferation (i.e., tumor growth) and inappropriate cell migration (i.e., tissue invasion and metastasis) define melanoma (3–7) . Previous studies have defined oscillatory gene expression profiles that promote melanocyte “proliferative”versus “invasive” phenotypes (3, 4, 7) . For instance, proliferative melanocytes generally exhibit high levels of transcription factor MITF and other genes (7, 8), although how this phenotype is spatially arranged and modulated within the tumor microenvironment remains poorly understood.  \nOur understanding of melanocyte biology and gene expression has relied on RNA measurement techniques, e.g., gene expression microarrays, bulk RNA sequencing, and single-cell RNA sequencing (scRNA-seq) . These techniques, however, lack spatial information and thus preclude insight into factors such as cell proximity to  \n1department of dermatology, University of california, davis, Sacramento, cA 95816, USA. 2nanoString technologies, a Bruker company, Seattle, WA 98109, USA. 3department of Biochemistry and Molecular Medicine, University of california, davis, Sacramento, cA 95816, USA. 4department of Pathology and Laboratory Medicine, University of california, davis, Sacramento, cA 95816, USA.  \n*[corresponding author. email: mkiuru@ucdavis.edu](corresponding author. email: mkiuru@ucdavis.edu)  \nlymphovasculat","cbCaimvz4ecreiyp","https://ap.wps.com/l/cbCaimvz4ecreiyp","pdf",18260709,12,"English","# Introduction\n# Results\n## Single-cell RNA-based spatial molecular imaging generates maps of gene expression within benign, malignant, and metastatic melanocytic neoplasms","[{\"question\":\"What approach is used to study spatial gene expression in melanoma?\",\"answer\":\"The study uses single-cell RNA-based spatial molecular imaging (RNA-SMI) to visualize in situ gene expression from patient-derived FFPE tumor specimens.\"},{\"question\":\"How many cells and what tumor types are analyzed?\",\"answer\":\"Spatial gene expression is examined across 203,472 cells in benign and malignant melanocytic neoplasms, including melanocytic nevi, primary invasive melanomas, and metastatic melanomas.\"},{\"question\":\"Which gene markers from metastatic niches relate to prognosis?\",\"answer\":\"Metastatic niches show up-regulation of CDK2 and FABP5, and both independently predict poor clinical outcome in melanoma patients based on Cox regression analysis.\"}]","Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors - Genetics | PDF",1790009127]